資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://ir.cnu.edu.tw/handle/310902800/34680
|
| 標題: | Association between hypomagnesemia and mortality among dialysis patients: a systematic review and meta-analysis |
| 作者: | Huang, Chi-Ya
Yang, Chi-Chen
Hung, Kuo-Chuan
Jiang, Ming-Yan
Huang, Yun-Ting
Hwang, Jyh-Chang
Hsieh, Chih-Chieh
Chuang, Min-Hsiang
Chen, Jui-Yi |
| 貢獻者: | Chi Mei Hospital
Chi Mei Hospital
Chi Mei Hospital
Department of Hospital and Health Care Administration, Chia Nan University of Pharmacy & Science
Department of Health and Nutrition, Chia Nan University of Pharmacy & Science |
| 關鍵字: | cardiovascular risk-factors
serum magnesium levels
hemodialysis-patients
significant predictor |
| 日期: | 2022 |
| 上傳時間: | 2023-12-11 14:04:50 (UTC+8) |
| 出版者: | PEERJ INC |
| 摘要: | Background: Malnutrition-inflammation-atherosclerosis (MIA) syndrome is caused by the inflammatory cytokines in end stage renal disease (ESRD) patients, and MIA complex-related factors may be associated with hypomagnesemia and mortality. However, the association between serum magnesium level and mortality for dialysis patients is still not clear. Additionally, no meta-analysis has investigated the impact of serum magnesium on peritoneal dialysis and hemodialysis, separately. Methods: We searched published studies in PubMed, Embase, Cochrane, Collaboration Central Register of Controlled Clinical Trials, and Cochrane Systematic Reviews through April 2022. Studies associated with serum magnesium and all-cause mortality or cardiovascular (CV) mortality in ESRD on kidney replacement therapy (KRT) patients were included. A hazard ratio (HR) with 95% confidence intervals (CI) was used to report the outcomes. Results: Twenty-one studies involving 55,232 patients were included. Overall, there was a significant association between hypomagnesemia and all-cause mortality for dialysis patients (HR: 1.67, 95% CI [1.412-2.00], p < 0.001; certainty of evidence: moderate) using a mixed unadjusted and adjusted HR for analysis. There was also a significantly increased risk of CV mortality for individuals with hypomagnesemia compared with the non-hypomagnesemia group (HR 1.56, 95% CI [1.08-2.25], p < 0.001; certainty of evidence: moderate). In addition, a subgroup analysis demonstrated that hypomagnesemia was associated with a high risk of both all-cause mortality and CV mortality (all-cause mortality, HR:1.80, 95% CI [1.48-2.19]; CV mortality, HR:1.84, 95% CI [1.10-3.07]) in hemodialysis (HD) patients, but not in participants receiving peritoneal dialysis (PD; all-cause mortality, HR:1.26, 95% CI [0.84-1.91]; CV mortality, HR:0.66, 95% CI [0.22-2.00]). The systematic review protocol was prespecified and registered in PROSPERO [CRD42021256187]. Conclusions: Hypomagnesemia may be a significant risk factor for all-cause mortality and CV mortality in KRT patients, especially in those receiving hemodialysis. However, because of the limited certainty of evidence, more studies are required to investigate this association. |
| 關聯: | PeerJ, v.10 |
| 顯示於類別: | [醫務管理系(所)] 期刊論文
[保健營養系(所) ] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 246 | 檢視/開啟 | | peerj.14203.pdf | | 934Kb | Adobe PDF | 106 | 檢視/開啟 |
|
在CNU IR中所有的資料項目都受到原著作權保護.
|
